Flagship Pioneering Fund VII General Partner LLC - Feb 27, 2023 Form 3 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
10%+ Owner
Signature
Flagship Pioneering Fund VII General Partner LLC, By: Flagship Pioneering, Inc., its manager, By: /s/ Noubar B. Afeyan, PhD., Chief Executive Officer
Stock symbol
OMGA
Transactions as of
Feb 27, 2023
Transactions value $
$0
Form type
3
Date filed
2/27/2023, 04:20 PM
Previous filing
Jul 7, 2022
Next filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OMGA Common Stock 1.33M Feb 27, 2023 By Flagship Pioneering Fund VII, L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 27, 2023, Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") purchased 1,329,324 shares of the Issuer's Common Stock in a registered direct offering at a price of $5.78 per share pursuant to a Securities Purchase Agreement dated February 22, 2023.
F2 Shares held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Fund VII GP. Noubar B. Afeyan, Ph.D. is the Chief Executive Officer, sole shareholder and director of Flagship Pioneering. Each of the reporting persons except Flagship Fund VII disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.